Connect
MJA
MJA

Putting the “good” into Good Clinical Practice

Tanya Symons, Steve Webb and John R Zalcberg
Med J Aust 2021; 214 (2): . || doi: 10.5694/mja2.50908
Published online: 1 February 2021

Current Good Clinical Practice guidelines are bureaucratic and should align with less burdensome examples of international trial policy

Clinical trials must be conducted in ways that protect participants and produce reliable results. Both are central tenets of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice (GCP) guideline.1 The ICH GCP guideline was developed to harmonise the conduct of trials across world regions and, since the mid‐1990s, its core principles have provided the bedrock for trial conduct. However, the devil is in the detail and, in the case of the ICH GCP guideline, that detail (and the interpretation of each word) has far‐reaching consequences.

  • Tanya Symons1
  • Steve Webb2
  • John R Zalcberg3

  • 1 University of Sydney, Sydney, NSW
  • 2 Royal Perth Hospital, Perth, WA
  • 3 Monash University, Melbourne, VIC

Correspondence: tanya.symons@sydney.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.